U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07813208) titled 'Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival' on Sept. 02.
Brief Summary: The study aims to conduct a real-world investigation of children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in China, assessing their diagnosis, treatment status, survival outcomes, and prognostic factors. The research will involve children diagnosed with Ph+ ALL between January 1, 2015, and December 31, 2024. Our objective is to understand the incidence and prognosis of CML-like ALL, compare the diagnostic and treatment differences between CML-like ALL and typical Ph+ ALL, and provide clinical evidence for...